Jiajia Wang

6PUBLICATIONS
2CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersFood engineeringCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
Tumor-Derived HMGB1 Orchestrates Lysosomal Metabolic Reprogramming for M1 Macrophage Polarization.

|Sep 15, 2025
Enhancement of Targeted and Antitumor Effects of M1 Macrophages Based on Bioorthogonal Reactions.

Xin Ding, Yang Zhang, Songshen Chu

|Nov 01, 2024
Ac34deoGlcNAz: A Selective Probe for Identifying O-GlcNAc-Modified Proteins in Prostate Cancer.

Guoliang Xu, Jiangtao Zhu, Xihao Wang

|May 22, 2024
Longer fatty acid-protected GalNAz enables efficient labeling of proteins in living cells with minimized S-glyco modification.

Xin Ding, Menghe Wang, Renhao Chang

|May 13, 2024
Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling.

Jiajia Wang, Wei Cao, Wei Zhang

|May 02, 2024
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.

Jing Ma, Yutong Chen, Tao Li

Pageof 1

Frequent Collaborators

2 joint publications

Chaojie Wang

1 joint publications

Jing Ma